Physician profile
Jay Alan Heilmann
NPI 1932192440
$1,861.70
in general payments reported to CMS, 2019-2025
14 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2020: $136 · 2021: $65.92 · 2022: $162 · 2023: $268 · 2024: $438 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $972.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $504.96 | 2019-2025 | Total30, Wavelight Refractive Suite, Precision7 |
| Johnson & Johnson Vision Care, INC. | $435.86 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $229.43 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $222.80 | 2023-2024 | Infuse |
| Apellis Pharmaceuticals, INC. | $125.00 | 2024 | Syfovre |
| Abbvie INC. | $83.47 | 2022-2025 | |
| Coopervision INC. | $55.77 | 2019 | |
| Dompe US, INC. | $53.22 | 2025 | Oxervate |
| Harrow Eye, LLC | $39.63 | 2025 | Vevye |
| Carl Zeiss Meditec, INC. | $31.60 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $28.34 | 2024 | Eylea Hd |
| Allergan, INC. | $21.26 | 2020 | |
| Biotissue Holdings INC. | $18.51 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $11.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Heilmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.